[18F]SMS-5368

N/A

Report date: 2025/11/24 17:31:45

NME

Base Information

Drug Name[18F]SMS-5368

Drug Alias Name[18F]SMS-5368

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionPositron-emission tomography enhancersAnti-PSMA

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Tennessee

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Tennessee

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A